Sandra Abrevaya is the founder of Synapticure. Synapticure has raised $40M in total funding. Latest round: Series A. Based in Chicago, IL.
Sandra Abrevaya is the CEO and co-founder of Synapticure, a teleneurology company focused on personalized care for patients with neurodegenerative diseases. She was recognized as one of Entrepreneur's Top 20 Innovative Leaders in November 2024 for her work.
Full founder directory · Investor directory · Company funding database · Fundraising library